Last $0.0001 USD
Change Today 0.0001 / 50.00%
Volume 23.6M
SVFC On Other Exchanges
Symbol
Exchange
OTC US
As of 11:03 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

intellicell biosciences inc (SVFC) Snapshot

Open
$0.0001
Previous Close
$0.0001
Day High
$0.0001
Day Low
$0.0001
52 Week High
03/11/14 - $0.01
52 Week Low
02/26/15 - $0.0001
Market Cap
1.2M
Average Volume 10 Days
35.6M
EPS TTM
$-0.02
Shares Outstanding
7.9B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTELLICELL BIOSCIENCES INC (SVFC)

Related News

No related news articles were found.

intellicell biosciences inc (SVFC) Related Businessweek News

No Related Businessweek News Found

intellicell biosciences inc (SVFC) Details

IntelliCell BioSciences, Inc. operates as a regenerative medicine company in the United States. It develops and commercializes regenerative medicine using adult autologous stromal vascular fraction cells derived from the blood vessels in adipose tissue. The company’s products are intended to treat various clinical conditions, such as aesthetic conditions, orthopedic and sports injuries, and pain, as well as cardiac, gastrointestinal, periodontal, and autistic disorders. It also focuses on undertaking clinical studies in partnership with universities and hospitals for osteoarthritis, gum regeneration, non-healing diabetic ulcers, multiple sclerosis, cartilage regeneration, tendon repair, facial lines and wrinkles, chronic migraine headache, bone regeneration, and hair regeneration indications. In addition, the company is involved in sourcing, selling, and distributing laboratory equipment and supplies, which are used in tissue processing activities. It also licenses its products in Canada, Australia, New Zealand, and Thailand. The company has a collaboration agreement with Hielscher Ultrasonics to develop closed processing system for cell therapy manufacturing. IntelliCell BioSciences, Inc. is based in New York, New York.

intellicell biosciences inc (SVFC) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $275.0K
Compensation as of Fiscal Year 2013.

intellicell biosciences inc (SVFC) Key Developments

IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

IntelliCell BioSciences, Inc. announced a license agreement for the indication of Diabetes Mellitus. Invigorcell will be filing an IND with the FDA for the indication of Diabetes Mellitus. Invigorcell is a biotech company that will utilize the technologies of IntelliCell BioSciences to develop innovative treatments for the normalization of metabolism in both Type 1 and Type 2 diabetes.

IntelliCell BioSciences Announces Collaboration with Hielscher Ultrasonics to Develop Closed Processing System for Cell Therapy Manufacturing

IntelliCell BioSciences, Inc. announced an agreement for the development of a new closed processing system for its cellular therapy manufacturing with Hielscher Ultrasonics. Under the agreement, Hielscher Ultrasonics will provide system design and engineering development for ultrasonic cavitation manufacturing, and IntelliCell Biosciences will use this system in its commercial application of its stromal vascular fraction cellular product, 'SVFC'. In order to separate the stem cells and other beneficial cell types from the fat tissue, the harvested tissue is treated ultrasonically. The ultrasound cavitation technology can be adjusted exactly to the required intensity to break the tissue so that the cells are released for separation, but mildly enough to prevent the stem cells from damage. To improve the ultrasonic cavitation technique, Hielscher developed for IntelliCell a unique ultrasonic reactor, which allows the sonication in a sterile, contamination-free environment.

IntelliCell BioSciences, Inc. announced delayed 10-Q filing

On 11/14/2014, IntelliCell BioSciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVFC:US $0.00 USD 0.0001

SVFC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $2.52 USD -0.0499
Biorestorative Therapies Inc $0.46 USD 0.00
Cytori Therapeutics Inc $1.19 USD +0.06
StemCells Inc $1.09 USD -0.0014
Vericel Corp $3.55 USD -0.05
View Industry Companies
 

Industry Analysis

SVFC

Industry Average

Valuation SVFC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTELLICELL BIOSCIENCES INC, please visit www.intellicellbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.